Ribozyme and omics

Rznomics has core competencies to meet a variety of unmet medical needs
through development of biopharmaceutical based on
RNA platform technology for cancer/intractable diseases
Molecular Genetics Lab


Our vision is to treat/conquer various human intractable diseases such as liver cancer, intractable cancers, degenerative diseases and genetic diseases through development of innovative RNA-based biopharmaceutical.

Advantages of technology